[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351745-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351745-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diagnostic-and-prognostic-value-of-lncspata8-as1-in-prostate-cancer-and-its-regulatory-effect-on-tumor-progression","Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progression","","Long noncoding RNAs (lncRNAs) are implicated in the initiation and progression of cancers, yet the roles and mechanisms of lncSPATA8-AS1 in prostate cancer remain unclear. This study investigates how lncSPATA8-AS1 influences prostate cancer (PCa) biology and delineates its molecular mechanism. Using the GSE179321 dataset and RT–qPCR, cellular functional assays and RNA interaction experiments were performed to define regulatory effects on tumor progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diagnostic-and-prognostic-value-of-lncspata8-as1-in-prostate-cancer-and-its-regulatory-effect-on-tumor-progression/351745/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diagnostic-and-prognostic-value-of-lncspata8-as1-in-prostate-cancer-and-its-regulatory-effect-on-tumor-progression/351745.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical value does lncSPATA8-AS1 have in prostate cancer?","Question",{"text":63,"@type":64},"lncSPATA8-AS1 is upregulated in PCa tissues, serum, and cell lines. Clinically, it can serve as a biomarker for PCa diagnosis and prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does suppressing lncSPATA8-AS1 affect prostate cancer cells?",{"text":68,"@type":64},"Silencing lncSPATA8-AS1 inhibits PCa cell viability and suppresses EMT, migration, and invasion.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular axis is proposed for lncSPATA8-AS1 regulation?",{"text":72,"@type":64},"The study proposes an lncSPATA8-AS1/miR-328-5p/EPHB2 axis, where lncSPATA8-AS1 interacts to regulate EPHB2 through miR-328-5p, driving malignant behavior in PCa.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351745,1790637624,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","RESEARCH ARTICLE     \nDiagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progression  \nJinman Zhonga , Yanmeng Dengb, Xingru Qina and Quanxin Yanga  \naDepartment of Radiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; bCenter of Radiology, Shaanxi Traditional Chinese Medicine Hospital, Xi'an, China  \nABSTRACT  \nBackground: Long noncoding RNAs (lncRNAs) have significant impacts on the occurrence and development of many cancers. However, their effects and mechanisms on prostate cancer (PCa) remain largely unknown. The study was to explore the influence of lncSPATA8-AS1 on PCa and its molecular mechanism of action.  \nMethods: In the GSE179321 dataset, lncSPATA8-AS1, which was upregulated in PCa tumor tissues, was selected. The expression levels of lncSPATA8-AS1, miR-328-5p, and EPHB2 were detected using RT–qPCR. In vitro experiments were conducted to investigate the effects of lncSPATA8-AS1 on the malignant biological behaviors of PCa cells. Finally, the mechanism of lncSPATA8-AS1 was revealed through methods such as biotin-labeled RNA pull-down, luciferase assay, and rescue experiments.  \nResults: LncSPATA8-AS1 was upregulated in PCa tissues, serum, and cell lines. Clinically, lncSPATA8-AS1 could serve as a biomarker for the diagnosis and prognosis of PCa. Silencing lncSPATA8-AS1 can inhibit the cell viability of PCa tumor cells, suppress epithelial-mesenchymal transformation (EMT), cell migration, and invasion. Mechanistically, lncSPATA8-AS1 affects the expression of EPHB2 by interacting with miR-653-5p, thereby regulating the malignant biological behavior of PCa. Conclusion: The expression of lncSPATA8-AS1 is upregulated in the serum of PCa patients, and it has great potential as a biomarker for the diagnosis and prognosis of PCa. The lncSPATA8-AS1/miR-328-5p/EPHB2 axis drives the malignant biological behavior of prostate cancer.  \nARTICLE HISTORY  \nReceived 10 November 2025 Revised 19 May 2026 Accepted 19 May 2026  \nKEYWORDS  \nProstate cancer;  \nlncSPATA8-AS1; miR-328-5p; EPHB2; diagnosis  \n1. Introduction  \nProstate cancer (PCa) is the second most common malignant tumor among men worldwide, with an average annual increase of over 1.4 million cases.1 The incidence and mortality rates of PCa show significant regional differences, with a particularly high incidence in developed countries.2 Aging, genetic susceptibility gene mutations and abnormal androgen signaling pathways are the main factors contributing to PCa.3 Furthermore, a high-fat diet has also been proven to be a key environmental factor that promotes the progression of diseases.4 Adenocarcinoma is the main type of PCa. Its characteristic is the uncontrolled proliferation of prostate epithelial cells accompanied by the formation of atypical glands.5 Imaging examinations play a central role in the diagnosis, staging, and follow-up of prostate cancer. They help doctors detect tumors, assess their severity, and formulate treatment plans. However, its existence cannot be diagnosed independently. There may be false positives or false negatives, and it is not sensitive to small tumors, etc., which are some limitations. Therefore, it is necessary to explore new biomarkers to enhance the accuracy of diagnosis and treatment.  \nLncRNAs play a crucial role in epigenetic regulation, transcription, and post-transcriptional modification.6 They drive abnormal proliferation, EMT transformation, and migration and invasion of the tumor.7,8 For example, LINC01094 sponges miR-224-5p, thereby regulating the expression of CHSY1 and influencing the progression of glioma.9 LncRNA MIR497HG targets the miR-3918/ACTG2 axis to  \nCONTACT Jinman Zhong  [JinmanZhongdr@163.com](JinmanZhongdr@163.com)  Department of Radiology, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157, Xiwu Road, Xi'an, 710004, China  \n Supplemental data for this article can be accessed online at [https://doi.org/10.1080/15","cbCaigzxJt9oAnVb","https://ap.wps.com/l/cbCaigzxJt9oAnVb","pdf",3092719,14,"English","# Introduction\n## Background and clinical relevance of prostate cancer\n## Role of lncRNAs and rationale for studying lncSPATA8-AS1\n# Materials and Methods\n## Dataset selection and expression detection\n## In vitro functional assays\n## Mechanistic validation\n# Results\n## Expression of lncSPATA8-AS1 in PCa samples\n## Diagnostic and prognostic potential\n## Effects on viability, EMT, migration, and invasion\n## ceRNA-related regulatory mechanism\n# Conclusion","[{\"question\":\"What clinical value does lncSPATA8-AS1 have in prostate cancer?\",\"answer\":\"lncSPATA8-AS1 is upregulated in PCa tissues, serum, and cell lines. Clinically, it can serve as a biomarker for PCa diagnosis and prognosis.\"},{\"question\":\"How does suppressing lncSPATA8-AS1 affect prostate cancer cells?\",\"answer\":\"Silencing lncSPATA8-AS1 inhibits PCa cell viability and suppresses EMT, migration, and invasion.\"},{\"question\":\"What molecular axis is proposed for lncSPATA8-AS1 regulation?\",\"answer\":\"The study proposes an lncSPATA8-AS1/miR-328-5p/EPHB2 axis, where lncSPATA8-AS1 interacts to regulate EPHB2 through miR-328-5p, driving malignant behavior in PCa.\"}]","Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progression | PDF",1790095642,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5f3064367ff580a03b674ee16678d1a.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b50a28fcb3890fc2d8b2ea11d674288.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a041d239553ff8d8aa3e8dd8f250c691.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27db79c1881128c4d0114fed345e3695.webp",980,1306]